Litcius/Paper detail

Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways

Jing Chen, Na Li, Boxia Liu, Jun Ling, Wenjun Yang, Xiufeng Pang, Tao Li

2020Life Sciences63 citationsDOI

Topics & Concepts

Histone deacetylaseHistone deacetylase inhibitorCancer researchBreast cancerHedgehog signaling pathwayMetastasisSignallingChemistrySignal transductionSTAT3MedicineCancerHistonePharmacologyInternal medicineBiologyCell biologyBiochemistryGeneHistone Deacetylase Inhibitors ResearchCytokine Signaling Pathways and InteractionsEpigenetics and DNA Methylation
Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways | Litcius